Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06028984 · ClinicalTrials.gov registry record · NA
Self-guided Treatment for Depression
A NA study of Major Depressive Disorder, sponsored by Big Health.
- Active
- Registry status
- NA
- Development phase
- 248
- Enrollment target
- 1
- Study location
NCT06028984: Active NA study of Major Depressive Disorder, sponsored by Big Health.
NCT06028984 is a NA study of Major Depressive Disorder that is active but no longer recruiting, run by Big Health. The registered enrollment target is 248 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06028984, a NA study of Major Depressive Disorder, is active but no longer recruiting, sponsored by Big Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the efficacy and safety of a self-guided digital therapeutic app for the adjunct treatment of Major Depressive Disorder compared to a control app in adolescents and adults.
Conditions Studied
Interventions
- DEVICE Intervention app
- OTHER Control app
Study Locations (1)
California
- Big Health, Inc. - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2023-10-12 |
| Est. Completion | 2025-09 |
| Phase | NA |
What the registry record for NCT06028984 still lists
NCT06028984 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (34% lower).
The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Intervention app is the first listed.
NCT06028984 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06028984 about?
NCT06028984 is a clinical study titled "Self-guided Treatment for Depression". This study will examine the efficacy and safety of a self-guided digital therapeutic app for the adjunct treatment of Major Depressive Disorder compared to a control app in adolescents and adults.
What is the current status of trial NCT06028984?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 248 participants. The study started on 2023-10-12. Estimated completion is 2025-09.
What conditions does trial NCT06028984 study?
This clinical trial studies the following conditions: Major Depressive Disorder.
What interventions are being tested in trial NCT06028984?
The interventions under investigation include: Intervention app (DEVICE), Control app (OTHER).
Who is sponsoring clinical trial NCT06028984?
This trial is sponsored by Big Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06028984 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06028984's enrollment target sits among peer trials
248 61st of 282 higher than 222 of 282 other Major Depressive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Major Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
RECRUITING · NA
-
Neural Correlates of Stress and Perceived Control in Adolescent Depression
RECRUITING · NA
-
Positive Processes and Transition to Health (PATH)
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Amygdala Neurofeedback for Depression - Large Scale Clinical Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI